Annual EBITDA
$2.95 B
-$18.36 B-86.14%
31 December 2023
Summary:
Merck & Co annual earnings before interest, taxes, depreciation & amortization is currently $2.95 billion, with the most recent change of -$18.36 billion (-86.14%) on 31 December 2023. During the last 3 years, it has fallen by -$7.23 billion (-70.98%). MRK annual EBITDA is now -88.04% below its all-time high of $24.71 billion, reached on 31 December 2014.MRK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$3.98 B
-$3.46 B-46.51%
30 September 2024
Summary:
Merck & Co quarterly earnings before interest, taxes, depreciation & amortization is currently $3.98 billion, with the most recent change of -$3.46 billion (-46.51%) on 30 September 2024. Over the past year, it has dropped by -$2.97 billion (-42.68%). MRK quarterly EBITDA is now -70.60% below its all-time high of $13.55 billion, reached on 31 December 2014.MRK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$17.62 B
-$2.97 B-14.41%
30 September 2024
Summary:
Merck & Co TTM earnings before interest, taxes, depreciation & amortization is currently $17.62 billion, with the most recent change of -$2.97 billion (-14.41%) on 30 September 2024. Over the past year, it has increased by +$5.30 billion (+43.01%). MRK TTM EBITDA is now -28.69% below its all-time high of $24.71 billion, reached on 31 December 2014.MRK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.1% | -42.7% | +43.0% |
| 3 y3 years | -71.0% | -36.0% | +53.3% |
| 5 y5 years | -78.9% | +16.4% | +11.0% |
MRK EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -86.1% | at low | -46.5% | +195.9% | -23.6% | +155.1% |
| 5 y | 5 years | -86.1% | at low | -46.5% | +195.9% | -23.6% | +155.1% |
| alltime | all time | -88.0% | +208.1% | -70.6% | +195.9% | -28.7% | +2134.2% |
Merck & Co EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.98 B(-46.5%) | $17.62 B(-14.4%) |
| June 2024 | - | $7.45 B(+7.1%) | $20.58 B(+129.2%) |
| Mar 2024 | - | $6.96 B(-1001.2%) | $8.98 B(+30.0%) |
| Dec 2023 | $2.95 B(-86.1%) | -$772.00 M(-111.1%) | $6.91 B(-43.9%) |
| Sept 2023 | - | $6.95 B(-267.3%) | $12.32 B(+21.3%) |
| June 2023 | - | -$4.16 B(-185.1%) | $10.15 B(-49.2%) |
| Mar 2023 | - | $4.88 B(+5.2%) | $19.97 B(-6.3%) |
| Dec 2022 | $21.32 B(+19.1%) | $4.64 B(-3.1%) | $21.32 B(-1.4%) |
| Sept 2022 | - | $4.79 B(-15.5%) | $21.63 B(-6.2%) |
| June 2022 | - | $5.67 B(-9.0%) | $23.06 B(+15.1%) |
| Mar 2022 | - | $6.22 B(+25.7%) | $20.05 B(+12.0%) |
| Dec 2021 | $17.90 B(+75.8%) | $4.95 B(-20.4%) | $17.90 B(+55.8%) |
| Sept 2021 | - | $6.22 B(+135.0%) | $11.49 B(+27.9%) |
| June 2021 | - | $2.65 B(-35.1%) | $8.99 B(-12.5%) |
| Mar 2021 | - | $4.08 B(-380.3%) | $10.27 B(-7.2%) |
| Dec 2020 | $10.18 B(-10.5%) | -$1.46 B(-139.2%) | $11.06 B(-6.5%) |
| Sept 2020 | - | $3.72 B(-5.3%) | $11.82 B(+2.5%) |
| June 2020 | - | $3.92 B(-19.4%) | $11.53 B(-4.5%) |
| Mar 2020 | - | $4.87 B(-807.0%) | $12.07 B(+6.1%) |
| Dec 2019 | $11.37 B(-18.7%) | -$689.00 M(-120.1%) | $11.37 B(-28.3%) |
| Sept 2019 | - | $3.42 B(-23.3%) | $15.87 B(-3.2%) |
| June 2019 | - | $4.46 B(+7.0%) | $16.39 B(+5.8%) |
| Mar 2019 | - | $4.17 B(+9.7%) | $15.50 B(+10.8%) |
| Dec 2018 | $13.99 B(+17.1%) | $3.81 B(-3.6%) | $13.99 B(+4.2%) |
| Sept 2018 | - | $3.95 B(+10.6%) | $13.42 B(+21.8%) |
| June 2018 | - | $3.57 B(+33.9%) | $11.02 B(-2.0%) |
| Mar 2018 | - | $2.67 B(-17.6%) | $11.24 B(-5.9%) |
| Dec 2017 | $11.95 B(+10.4%) | $3.24 B(+109.7%) | $11.95 B(+37.0%) |
| Sept 2017 | - | $1.54 B(-59.3%) | $8.72 B(-23.6%) |
| June 2017 | - | $3.79 B(+12.3%) | $11.41 B(+5.2%) |
| Mar 2017 | - | $3.38 B(>+9900.0%) | $10.84 B(+0.2%) |
| Dec 2016 | $10.82 B(-13.1%) | $9.00 M(-99.8%) | $10.82 B(-19.0%) |
| Sept 2016 | - | $4.23 B(+31.2%) | $13.36 B(+0.8%) |
| June 2016 | - | $3.23 B(-3.9%) | $13.26 B(+5.0%) |
| Mar 2016 | - | $3.36 B(+31.9%) | $12.62 B(+1.4%) |
| Dec 2015 | $12.45 B(-49.6%) | $2.54 B(-38.4%) | $12.45 B(-46.9%) |
| Sept 2015 | - | $4.13 B(+59.6%) | $23.45 B(+3.7%) |
| June 2015 | - | $2.59 B(-18.6%) | $22.61 B(-5.2%) |
| Mar 2015 | - | $3.18 B(-76.5%) | $23.86 B(-3.4%) |
| Dec 2014 | $24.71 B(+85.3%) | $13.55 B(+311.6%) | $24.71 B(+70.0%) |
| Sept 2014 | - | $3.29 B(-14.1%) | $14.54 B(-1.0%) |
| June 2014 | - | $3.83 B(-5.0%) | $14.69 B(+5.2%) |
| Mar 2014 | - | $4.03 B(+19.3%) | $13.96 B(+4.7%) |
| Dec 2013 | $13.33 B(-18.8%) | $3.38 B(-1.9%) | $13.33 B(+1.5%) |
| Sept 2013 | - | $3.44 B(+11.1%) | $13.14 B(-4.9%) |
| June 2013 | - | $3.10 B(-9.0%) | $13.81 B(-10.1%) |
| Mar 2013 | - | $3.41 B(+7.0%) | $15.37 B(-6.5%) |
| Dec 2012 | $16.43 B(+6.3%) | $3.19 B(-22.7%) | $16.43 B(-2.6%) |
| Sept 2012 | - | $4.12 B(-11.5%) | $16.86 B(-1.8%) |
| June 2012 | - | $4.66 B(+4.1%) | $17.17 B(+6.1%) |
| Mar 2012 | - | $4.47 B(+23.7%) | $16.19 B(+4.7%) |
| Dec 2011 | $15.46 B(+58.5%) | $3.62 B(-18.4%) | $15.47 B(+17.2%) |
| Sept 2011 | - | $4.43 B(+20.6%) | $13.19 B(+16.6%) |
| June 2011 | - | $3.67 B(-1.9%) | $11.31 B(+2.7%) |
| Mar 2011 | - | $3.75 B(+179.3%) | $11.01 B(+12.9%) |
| Dec 2010 | $9.75 B(-46.8%) | $1.34 B(-47.4%) | $9.75 B(-40.1%) |
| Sept 2010 | - | $2.55 B(-24.4%) | $16.29 B(-15.8%) |
| June 2010 | - | $3.37 B(+35.8%) | $19.34 B(+4.4%) |
| Mar 2010 | - | $2.48 B(-68.5%) | $18.52 B(+1.1%) |
| Dec 2009 | $18.33 B(+55.1%) | $7.88 B(+40.7%) | $18.33 B(+41.7%) |
| Sept 2009 | - | $5.60 B(+119.1%) | $12.93 B(+40.0%) |
| June 2009 | - | $2.56 B(+11.8%) | $9.23 B(+0.4%) |
| Mar 2009 | - | $2.29 B(-8.0%) | $9.19 B(-22.2%) |
| Dec 2008 | $11.81 B(+55.3%) | $2.49 B(+30.6%) | $11.81 B(+3.4%) |
| Sept 2008 | - | $1.90 B(-24.3%) | $11.42 B(+2.3%) |
| June 2008 | - | $2.51 B(-48.7%) | $11.17 B(+5.4%) |
| Mar 2008 | - | $4.91 B(+134.1%) | $10.60 B(+39.4%) |
| Dec 2007 | $7.61 B(+27.7%) | $2.10 B(+26.8%) | $7.61 B(+19.6%) |
| Sept 2007 | - | $1.65 B(-15.0%) | $6.36 B(+9.3%) |
| June 2007 | - | $1.95 B(+1.7%) | $5.82 B(-0.2%) |
| Mar 2007 | - | $1.91 B(+125.2%) | $5.83 B(-2.0%) |
| Dec 2006 | $5.96 B(-21.3%) | $849.20 M(-23.7%) | $5.96 B(-11.7%) |
| Sept 2006 | - | $1.11 B(-43.1%) | $6.74 B(-10.6%) |
| June 2006 | - | $1.96 B(-3.7%) | $7.54 B(-0.6%) |
| Mar 2006 | - | $2.03 B(+24.3%) | $7.59 B(+0.2%) |
| Dec 2005 | $7.57 B(-7.8%) | $1.64 B(-14.7%) | $7.57 B(+1.5%) |
| Sept 2005 | - | $1.92 B(-4.4%) | $7.46 B(+0.9%) |
| June 2005 | - | $2.00 B(-0.7%) | $7.40 B(-7.5%) |
| Mar 2005 | - | $2.02 B(+32.3%) | $8.00 B(-2.5%) |
| Dec 2004 | $8.21 B | $1.53 B(-17.7%) | $8.21 B(-7.4%) |
| Sept 2004 | - | $1.85 B(-29.0%) | $8.87 B(-9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $2.61 B(+17.3%) | $9.78 B(+1.5%) |
| Mar 2004 | - | $2.22 B(+1.9%) | $9.63 B(-2.4%) |
| Dec 2003 | $9.88 B(-4.2%) | $2.18 B(-21.1%) | $9.87 B(-6.2%) |
| Sept 2003 | - | $2.77 B(+12.2%) | $10.52 B(+2.2%) |
| June 2003 | - | $2.46 B(+0.1%) | $10.29 B(-2.4%) |
| Mar 2003 | - | $2.46 B(-13.0%) | $10.55 B(-0.4%) |
| Dec 2002 | $10.32 B(-0.9%) | $2.83 B(+11.7%) | $10.59 B(+6.9%) |
| Sept 2002 | - | $2.53 B(-6.9%) | $9.91 B(-4.5%) |
| June 2002 | - | $2.72 B(+8.7%) | $10.38 B(-0.1%) |
| Mar 2002 | - | $2.50 B(+16.6%) | $10.39 B(-0.2%) |
| Dec 2001 | $10.41 B(-2.6%) | $2.15 B(-28.5%) | $10.41 B(-7.7%) |
| Sept 2001 | - | $3.01 B(+10.1%) | $11.28 B(+2.5%) |
| June 2001 | - | $2.73 B(+8.2%) | $11.00 B(+1.0%) |
| Mar 2001 | - | $2.52 B(-16.2%) | $10.89 B(+1.9%) |
| Dec 2000 | $10.69 B(+18.0%) | $3.01 B(+10.2%) | $10.69 B(+3.8%) |
| Sept 2000 | - | $2.73 B(+4.4%) | $10.30 B(+5.0%) |
| June 2000 | - | $2.62 B(+13.0%) | $9.81 B(+4.5%) |
| Mar 2000 | - | $2.32 B(-11.7%) | $9.39 B(+3.6%) |
| Dec 1999 | $9.06 B(+22.5%) | $2.62 B(+16.7%) | $9.06 B(+7.1%) |
| Sept 1999 | - | $2.25 B(+2.4%) | $8.46 B(-1.1%) |
| June 1999 | - | $2.20 B(+10.4%) | $8.55 B(+7.7%) |
| Mar 1999 | - | $1.99 B(-1.9%) | $7.94 B(+7.4%) |
| Dec 1998 | $7.39 B(+10.3%) | $2.03 B(-13.4%) | $7.39 B(-4.3%) |
| Sept 1998 | - | $2.34 B(+47.4%) | $7.73 B(+12.8%) |
| June 1998 | - | $1.59 B(+10.3%) | $6.85 B(+0.9%) |
| Mar 1998 | - | $1.44 B(-39.0%) | $6.79 B(+1.3%) |
| Dec 1997 | $6.70 B(+13.3%) | $2.36 B(+61.3%) | $6.70 B(+4.0%) |
| Sept 1997 | - | $1.46 B(-4.0%) | $6.44 B(+1.9%) |
| June 1997 | - | $1.52 B(+12.7%) | $6.32 B(+3.2%) |
| Mar 1997 | - | $1.35 B(-35.6%) | $6.13 B(+3.7%) |
| Dec 1996 | $5.91 B(+12.3%) | $2.10 B(+56.0%) | $5.91 B(+5.2%) |
| Sept 1996 | - | $1.35 B(+1.1%) | $5.62 B(+2.4%) |
| June 1996 | - | $1.33 B(+17.4%) | $5.48 B(+2.3%) |
| Mar 1996 | - | $1.13 B(-37.2%) | $5.36 B(+1.9%) |
| Dec 1995 | $5.26 B(-0.3%) | $1.81 B(+48.9%) | $5.26 B(+0.4%) |
| Sept 1995 | - | $1.21 B(+0.2%) | $5.24 B(+0.0%) |
| June 1995 | - | $1.21 B(+17.2%) | $5.24 B(-0.7%) |
| Mar 1995 | - | $1.03 B(-42.2%) | $5.28 B(-0.1%) |
| Dec 1994 | $5.28 B(+22.8%) | $1.79 B(+47.6%) | $5.28 B(+0.2%) |
| Sept 1994 | - | $1.21 B(-2.8%) | $5.27 B(+4.0%) |
| June 1994 | - | $1.25 B(+20.2%) | $5.07 B(+25.6%) |
| Mar 1994 | - | $1.04 B(-41.7%) | $4.03 B(+3.8%) |
| Dec 1993 | $4.30 B(+12.8%) | $1.78 B(+76.5%) | $3.89 B(+32.0%) |
| Sept 1993 | - | $1.01 B(+373.8%) | $2.94 B(+4.0%) |
| June 1993 | - | $212.40 M(-76.1%) | $2.83 B(-20.3%) |
| Mar 1993 | - | $890.30 M(+6.7%) | $3.55 B(+1.7%) |
| Dec 1992 | $3.81 B(+13.0%) | $834.40 M(-6.5%) | $3.49 B(+1.4%) |
| Sept 1992 | - | $892.80 M(-4.2%) | $3.44 B(+3.1%) |
| June 1992 | - | $931.70 M(+11.9%) | $3.34 B(+1.6%) |
| Mar 1992 | - | $832.60 M(+6.1%) | $3.29 B(+1.4%) |
| Dec 1991 | $3.37 B(+16.1%) | $784.50 M(-0.7%) | $3.24 B(+3.4%) |
| Sept 1991 | - | $790.40 M(-10.2%) | $3.14 B(+3.9%) |
| June 1991 | - | $880.30 M(+11.9%) | $3.02 B(+6.5%) |
| Mar 1991 | - | $786.50 M(+16.0%) | $2.84 B(+6.9%) |
| Dec 1990 | $2.91 B(+18.2%) | $678.10 M(+0.6%) | $2.65 B(+5.0%) |
| Sept 1990 | - | $673.80 M(-3.3%) | $2.53 B(+3.9%) |
| June 1990 | - | $696.80 M(+15.6%) | $2.43 B(-26.8%) |
| Mar 1990 | - | $602.70 M(+9.1%) | $3.32 B(-22.6%) |
| Dec 1989 | $2.46 B(+18.6%) | $552.40 M(-4.7%) | $4.29 B(+258.1%) |
| Sept 1989 | - | $579.60 M(-63.4%) | $1.20 B(-42.6%) |
| June 1989 | - | $1.59 B(+0.9%) | $2.09 B(+4.3%) |
| Mar 1989 | - | $1.57 B(-161.9%) | $2.00 B(+7.2%) |
| Dec 1988 | $2.07 B(+31.2%) | -$2.54 B(-272.8%) | $1.87 B(-11.4%) |
| Sept 1988 | - | $1.47 B(-2.1%) | $2.11 B(+8.3%) |
| June 1988 | - | $1.50 B(+4.4%) | $1.95 B(+14.8%) |
| Mar 1988 | - | $1.44 B(-162.5%) | $1.69 B(+23.8%) |
| Dec 1987 | $1.58 B(+27.9%) | -$2.30 B(-275.9%) | $1.37 B(-20.8%) |
| Sept 1987 | - | $1.31 B(+4.6%) | $1.73 B(+17.1%) |
| June 1987 | - | $1.25 B(+12.4%) | $1.48 B(+19.8%) |
| Mar 1987 | - | $1.11 B(-157.3%) | $1.23 B(+18.2%) |
| Dec 1986 | $1.24 B(+20.8%) | -$1.94 B(-284.0%) | $1.04 B(-15.4%) |
| Sept 1986 | - | $1.05 B(+4.8%) | $1.23 B(+19.2%) |
| June 1986 | - | $1.00 B(+9.1%) | $1.03 B(+14.1%) |
| Mar 1986 | - | $921.10 M(-152.6%) | $904.60 M(+7.7%) |
| Dec 1985 | $1.02 B(+6.6%) | -$1.75 B(-304.5%) | $839.80 M(+6.5%) |
| Sept 1985 | - | $855.80 M(-2.5%) | $788.50 M(-0.3%) |
| June 1985 | - | $877.40 M(+2.5%) | $790.60 M(-1.7%) |
| Mar 1985 | - | $856.30 M(-147.5%) | $804.50 M(+1.0%) |
| Dec 1984 | $958.80 M | -$1.80 B(-309.9%) | $796.80 M(-69.3%) |
| Sept 1984 | - | $857.90 M(-3.7%) | $2.60 B(+49.3%) |
| June 1984 | - | $891.30 M(+5.0%) | $1.74 B(+105.0%) |
| Mar 1984 | - | $848.60 M | $848.60 M |
FAQ
- What is Merck & Co annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Merck & Co?
- What is Merck & Co annual EBITDA year-on-year change?
- What is Merck & Co quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Merck & Co?
- What is Merck & Co quarterly EBITDA year-on-year change?
- What is Merck & Co TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Merck & Co?
- What is Merck & Co TTM EBITDA year-on-year change?
What is Merck & Co annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MRK is $2.95 B
What is the all time high annual EBITDA for Merck & Co?
Merck & Co all-time high annual earnings before interest, taxes, depreciation & amortization is $24.71 B
What is Merck & Co annual EBITDA year-on-year change?
Over the past year, MRK annual earnings before interest, taxes, depreciation & amortization has changed by -$18.36 B (-86.14%)
What is Merck & Co quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MRK is $3.98 B
What is the all time high quarterly EBITDA for Merck & Co?
Merck & Co all-time high quarterly earnings before interest, taxes, depreciation & amortization is $13.55 B
What is Merck & Co quarterly EBITDA year-on-year change?
Over the past year, MRK quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.97 B (-42.68%)
What is Merck & Co TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MRK is $17.62 B
What is the all time high TTM EBITDA for Merck & Co?
Merck & Co all-time high TTM earnings before interest, taxes, depreciation & amortization is $24.71 B
What is Merck & Co TTM EBITDA year-on-year change?
Over the past year, MRK TTM earnings before interest, taxes, depreciation & amortization has changed by +$5.30 B (+43.01%)